$ENTX
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
Healthcare
Sector
Biotechnology
Industry
Miranda J. Toledano
CEO
18
Employees
$1.11
Current Price
$64.20M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 1 | 1 | $26,000.00 | 20,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 2 | 2 | $38,300.00 | 30,000 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 4 | 7 | $120,970.00 | 90,500 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 5 | 8 | $140,882.20 | 101,500 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Germano Geno J Director | Purchase | 20,000 | $1.30 | $26,000.00 | View Details |
| Mar 5, 2026 | Ellis Sean Director | Purchase | 10,000 | $1.23 | $12,300.00 | View Details |
| Feb 12, 2026 | Rubin Steven D Director | Purchase | 5,000 | $1.49 | $7,450.00 | View Details |
| Feb 10, 2026 | Taitel Haya Director | Purchase | 7,500 | $1.48 | $11,100.00 | View Details |
| Feb 10, 2026 | Germano Geno J Director | Purchase | 20,000 | $1.49 | $29,800.00 | View Details |
| Feb 9, 2026 | Rubin Steven D Director | Purchase | 10,000 | $1.20 | $12,000.00 | View Details |
| Feb 9, 2026 | Ellis Sean Director | Purchase | 18,000 | $1.24 | $22,320.00 | View Details |
| Dec 29, 2025 | Toledano Miranda Jayne Director | Purchase | 11,000 | $1.81 | $19,912.20 | View Details |
Upcoming Earnings
Scheduled earnings reports
EPS
Estimated-$0.09
ActualN/A
Revenue
EstimatedN/A
ActualN/A
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Past Earnings
Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: